KIMBERLY TUPPER: Open Payments
NPI 1437785482 · SOUTHAVEN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$347 in 21 payments from 8 companies in 2025. Trend: 2023 $523 · 2024 $325 · 2025 $347
Food & beverage: $347
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 10 | $138 |
| Novo Nordisk Inc | 3 | $52 |
| Boston Scientific Corporation | 1 | $47 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Dexcom, Inc. | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 2 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
| ABBVIE INC. | 1 | $15 |
Products named: MOUNJARO, CDS - MCT/CEM Monitoring, Ozempic, AIRSUPRA, ZEPBOUND, Dexcom G6 Transmitter, VOQUEZNA, Kerendia.
Industry payments across MS — which companies pay providers there.
